Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Low-Risk Dividend Stocks to Invest In

In this article, we discuss 5 best low-risk dividend stocks to invest in. If you want to read our detailed analysis on dividend investment and their returns in the past, go directly to read 11 Best Low-Risk Dividend Stocks to Invest In

5. PepsiCo, Inc. (NASDAQ:PEP)

Dividend Yield as of December 7: 2.53%
Beta Value: 0.59

PepsiCo, Inc. (NASDAQ:PEP) is an American multinational food, snack, and beverage company that has raised its dividends consistently for the past 50 years. The company pays a quarterly dividend of $1.15 per share and has a dividend yield of of 2.53%, as of December 7.

In December, Deutsche Bank lifted its price target on PepsiCo, Inc. (NASDAQ:PEP) to $186 with a Hold rating on the shares, highlighting the company’s positive developments this year.

In Q3 2022, PepsiCo, Inc. (NASDAQ:PEP) reported revenue of $22 billion, which saw an 8.8% growth from the same period last year. The company’s organic revenue growth also showed a 16% year-over-year growth. For FY22, it expects to return $7.7 billion to shareholders, including $6.2 billion in dividends.

The number of hedge funds holding investments in PepsiCo, Inc. (NASDAQ:PEP) grew to 72 in Q3 2022, from 65 in the previous quarter. The stakes owned by these hedge funds have a total value of over $4.8 billion. Fundsmith LLP was the company’s leading stakeholder in Q3.

Follow Pepsico Inc (NASDAQ:PEP)

4. Johnson & Johnson (NYSE:JNJ)

Dividend Yield as of December 7: 2.57%
Beta Value: 0.57

One of the leading Big Pharma companies, Johnson & Johnson (NYSE:JNJ) was lauded by Morgan Stanley in December as the company plans to separate its Consumer Health segment into an independent company. The firm raised its price target on the stock to $178 with an Equal Weight rating on the shares.

Johnson & Johnson (NYSE:JNJ) currently pays a quarterly dividend of $1.13 per share and has a dividend yield of 2.57%, as of December 7. The company is one of the best dividend stocks on our list as it has raised its dividends for 60 years in a row.

As of the close of Q3 2022, 85 hedge funds in Insider Monkey’s database owned stakes in Johnson & Johnson (NYSE:JNJ), up from 83 in the previous quarter. The collective value of these stakes is over $5.4 billion. Among these hedge funds, Fisher Asset Management was the company’s leading stakeholder in Q3.

Here’s what Distillate Capital Partners LLC said about Johnson & Johnson (NYSE:JNJ) in its Q2 2022 investor letter:

Johnson & Johnson was among the 2 largest trims at around 1% each. Each stock was up 1% in the quarter compared to the 16% price decline for the S&P 500 and the positions were reduced as the valuations became somewhat less appealing, though still attractive enough to warrant inclusion.”

Follow Johnson & Johnson (NYSE:JNJ)

3. Pfizer Inc. (NYSE:PFE)

Dividend Yield as of December 7: 3.22%
Beta Value: 0.65

Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical and biotech company. In Q3 2022, the company reported revenue of $22.6 billion, which beat analysts’ consensus by $1.5 billion. Its cash position remained strong during the quarter, as it returned $6.7 billion to shareholders in dividends. The company’s strong balance sheet and consistent dividends make it one of the best dividend stocks to buy.

Pfizer Inc. (NYSE:PFE) offers a quarterly dividend of $0.40 per share for a dividend yield of 3.22%, as recorded on December 7. The company maintains a 12-year streak of consistent dividend growth.

Credit Suisse initiated its coverage of Pfizer Inc. (NYSE:PFE) in November with an Outperform rating and a $55 price target, highlighting the company’s Covid vaccines’ success in recent quarters.

Pfizer Inc. (NYSE:PFE) was a part of 77 hedge fund portfolios in Q3 2022, up from 70 in the previous quarter, as per Insider Monkey’s database. The collective value of stakes owned by these hedge funds is over $2.4 billion.

Diamond Hill Capital mentioned Pfizer Inc. (NYSE:PFE) in its Q3 2022 investor letter. Here is what the firm has to say:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.”

Follow Pfizer Inc (NYSE:PFE)

2. AT&T Inc. (NYSE:T)

Dividend Yield as of December 7: 5.79%
Beta Value: 0.72

AT&T Inc. (NYSE:T) is an American multinational telecommunications company that provides mobile phone services to its consumers. The company currently pays a quarterly dividend of $0.2775 per share and has a dividend yield of 5.79%, as of December 7. It has raised its payouts consistently for the past 23 years, which places it as one of the best dividend stocks on our list.

In October, Raymond James appreciated the company’s performance and its overall fundamentals. In view of this, the firm upgraded AT&T Inc. (NYSE:T) to Strong Buy with a $24 price target.

At the end of Q3 2022, 61 hedge funds tracked by Insider Monkey owned stakes in AT&T Inc. (NYSE:T), up from 55 a quarter earlier. The collective value of these stakes is over $1.53 billion.

Chartwell Investment Partners mentioned AT&T Inc. (NYSE:T) in its Q2 2022 investor letter. Here is what the firm has to say:

“In the Dividend Equity accounts, the three best performers in Q2 includes AT&T (NYSE:T, 2.5%), up 17.1%. AT&T completed the spin of the WarnerMedia business (HBO, CNN, etc.), and the market seemed to like the “back-to-basics” approach. Also, the telco business is expected to do relatively well in an inflationary environment.”

Follow At&T Inc. (NYSE:T)

1. Verizon Communications Inc. (NYSE:VZ)

Dividend Yield as of December 7: 7.08%
Beta Value: 0.36

Verizon Communications Inc. (NYSE:VZ) is a New York-based telecommunication services company that provides voice, video, and data services to its consumers. Morgan Stanley appreciated the growth in the company’s wireless and postpaid segments in October and maintained an Equal Weight rating on the stock with a $41 price target.

Verizon Communications Inc. (NYSE:VZ) has raised its dividends consistently for the past 16 years. The company currently pays a quarterly dividend of $0.6526 per share and has a dividend yield of 7.08%, as of December 7.

Verizon Communications Inc. (NYSE:VZ) saw growth in hedge fund positions in Q3 2022, as 62 funds in Insider Monkey’s database owned stakes in the company, up from 58 in the previous quarter. The collective value of these stakes is over $1.42 billion. Citadel Investment Group is the company’s leading stakeholder in Q3.

Mawer Investment Management mentioned Verizon Communications Inc. (NYSE:VZ) in its Q3 2022 investor letter. Here is what the firm has to say:

“There are a few other segments of our portfolios that displayed weakness in the quarter. Cable and telecommunication companies have been an area that has lagged the broader market as their worlds are increasingly colliding. Companies such as Verizon (NYSE:VZ) has been impacted as wireless operator is spending heavily to attract internet subscribers with fixed wired access and the cable companies are trying to build wireless businesses.”

Follow Verizon Communications Inc (NYSE:VZ)

You can also take a look at 12 Very High-Yield Dividend Stocks To Buy Now and 15 Best Dividend Stocks for Passive Income

Follow Insider Monkey on Twitter

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.